Clinical Trials Browser

Terminated × Oligoprogressive × pembrolizumab × Clear all

NCT05846659 2024-12-09

Study of PULSAR-ICI +/- IMSA101 in Patients with Oligoprogressive Solid Tumor Malignancies

Phase 2 Terminated

Oligoprogressive